About this trial
Patients requiring admission to the hospital due to a moderate and severe COVID-19 infection may differ in their ability to respond to viral infection and to eliminate viral load.
Several comorbidities and interventions like antivirotic or antiinflammatory treatment may also modify expected patients response and decrease of viral load.
In this observational study, evolution of selected inflammatory markers, indicators of severity of infection and patient characteristics will be followed and recorded in hospitalized patients with COVID-19.
Eligibility criteria
Qualifiers
SARS CoV2 positive test within last 14 day
bilateral infiltrates on chest X.ray or CT
need for oxygen to keep pulse oximetry saturation above 92% or other respiratory support measures (HFNO, non-invasive ventilation or invasive ventilation)
Disqualifiers
known history of intersticial lung disease
known history of congestive heart failure
Trial design
Treatments tested in this trial
- Not listed